Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Miyajima, Fabio ^a,b   Roberts, Paul ^a,c   Swale, Andrew ^a,b   Price, Valerie ^a,c   Jones, Maureen ^d   Horan, Michael ^d   Beeching, Nicholas ^a,e   Brazier, Jonathan ^f   Parry, Christopher ^a,b,g   Pendleton, Neil ^d   Pirmohamed, Munir ^a,b  

^a Camden and Islington National Health Service Foundation Trust   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; GLUTAMATE DEHYDROGENASE;

AGED; AGING; ARTICLE; BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIUM CARRIER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HOST SUSCEPTIBILITY; HUMAN; HUMAN EXPERIMENT; LONG TERM CARE; MALE; MASS SCREENING; NORMAL HUMAN; UNITED KINGDOM; DEMOGRAPHY; HETEROZYGOTE; ISOLATION AND PURIFICATION; STATISTICS;

CLOSTRIDIUM DIFFICILE;

AGED; AGED, 80 AND OVER; CARRIER STATE; CLOSTRIDIUM DIFFICILE; DEMOGRAPHY; FEMALE; GREAT BRITAIN; HUMANS; MALE; RESIDENCE CHARACTERISTICS;

EID: 80051962954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022804     Document Type: Article

References (33)

1. Kuijper EJ, Van Dissel JT, Wilcox MH, (2007) Clostridium difficile: Changing epidemiology and new treatment options. Current Opinion in Infectious Diseases 20: 376-383.
2. Warny M, Pepin J, Fang A, Killgore G, Thompson A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079-1084.
3. Deneve C, Janoir C, Poilane I, Fantinato C, Collignon A, (2009) New trends in Clostridium difficile virulence and pathogenesis. International Journal of Antimicrobial Agents 33.
4. Stabler RA, He M, Dawson L, Martin M, Valiente E, et al. (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10: R102 gb-2009-10-9-r102 [pii];10.1186/gb-2009-10-9-r102 [doi].
5. Dial S, Delaney JAC, Barkun AN, Suissa S, (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. Journal of the American Medical Association 294: 2989-2995.
6. Donta ST, Myers MG, (1982) Clostridium difficile toxin in asymptomatic neonates. Journal of Pediatrics 100: 431-434.
7. Matsuki S, Ozaki E, Shozu M, Inoue M, Shimizu S, et al. (2005) Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. International Microbiology 8: 43-48.
8. Gerding DN, Olson MM, Peterson LR, (1986) Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Archives of Internal Medicine 146: 95-100.
9. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RLP, et al. (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clinical Infectious Diseases 45: 992-998.
10. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN, (1998) Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351: 633-636.
11. Campbell RR, Beere D, Wilcock GK, Brown EM, (1988) Clostridium difficile in acute and long-stay elderly patients. Age and Ageing 17: 333-336.
12. Walker KJ, Gilliland SS, Vance-Bryan K, Moody JA, Larsson AJ, et al. (1993) Clostridium difficile colonization in residents of long-term care facilities: Prevalence and risk factors. Journal of the American Geriatrics Society 41: 940-946.
13. Rivera EV, Woods S, (2003) Prevalence of asymptomatic Clostridium difficile colonization in a nursing home population: A cross-sectional study. Journal of Gender-Specific Medicine 6: 27-30.
14. Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, et al. (2001) Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 50: 720-727.
15. Ozaki E, Kato H, Kita H, Karasawa T, Maegawa T, et al. (2004) Clostridium difficile colonization in healthy adults: Transient colonization and correlation with enterococcal colonization. J Med Microbiol 53: 167-172.
16. Simor AE, Yake SL, Tsimidis K, (1993) Infection due to Clostridium difficile among elderly residents of a long- term-care facility. Clinical Infectious Diseases 17: 672-678.
17. Brazier JS, Fitzgerald TC, Hosein I, Cefai C, Looker N, et al. (1999) Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: A study of 284 admissions of elderly patients to six general hospitals in Wales [3]. Journal of Hospital Infection 43: 317-319.
18. Kyne L, Warny M, Qamar A, Kelly CP, (2000) Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. New England Journal of Medicine 342: 390-397.
19. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE, et al. (2002) Clostridium difficile in long-term-care facilities for the elderly. Infection Control and Hospital Epidemiology 23: 696-703.
20. Ryan J, Murphy C, Twomey C, Paul Ross R, Rea MC, et al. (2010) Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: Prevalence and characteristics. Irish Journal of Medical Science 179: 245-250.
21. Rabbitt PMA, McInnes L, Diggle P, Holland F, Bent N, et al. (2004) The University of Manchester longitudinal study of cognition in normal healthy old age, 1983 through 2003. Aging, Neuropsychology, and Cognition 11: 245-279.
22. Lewis SJ, Heaton KW, (1997) Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 32: 920-924.
23. Brazier JS, (1993) Role of the laboratory in investigations of Clostridium difficile diarrhoea. Clinical Infectious Diseases 16: S228-S233.
24. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, et al. (2004) Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 42: 5710-5714.
25. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC, (1999) Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiology Letters 175: 261-266.
26. Health Protection Agency (2009) pp. 1-19 Clostridium difficile Ribotyping Network for England and Northern Ireland 2008/09 Report.
27. Eastwood K, Else P, Charlett A, Wilcox M, (2009) Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47: 3211-3217.
28. Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, et al. (2008) Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J Clin Microbiol 46: 1530-1533.
29. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, et al. (2010) Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. Journal of Bacteriology 192: 4904-4911.
30. Martinsen TC, Bergh K, Waldum HL, (2005) Gastric juice: A barrier against infectious diseases. Basic and Clinical Pharmacology and Toxicology 96: 94-102.
31. Hookman P, Barkin JS, (2009) Clostridium difficile associated infection, diarrhea and colitis. World Journal of Gastroenterology 15: 1554-1580.
32. Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R, (2007) Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. Microbiology and Immunology 51: 1209-1214.
33. Tatarowicz W, Seiberling M, Gerding DN, Gomez A, Monnot-Chase E, et al. (2010) Safety and Tolerability of an oral suspension of VP 20621, spores of a non-toxigenic Clostridium difficile strain, in healthy older subjects. Abstract Book- 3rd International Clostridium difficile Symposium 44.